strain needs to fulfill, is that it should be resistant to that particular antibiotic to avoid direct killing of the probiotic strain. Therefore, first of all L. plantarum was tested for its susceptibility to the antibiotics by the method of Bauer et al. 7 The antibiogram pattern indicated that L. plantarum was resistant to ampicillin, ciprofloxacin and ceftriaxone. This antibiogram pattern was further confirmed by agar-WDA. 8 10 7 CFUs of L. plantarum was spread plated on DeMan-Rogosa-Sharpe (MRS) agar plates. Wells of 5 mm diameter were punched in the agar plates and filled with 20 ml stock solution of each antibiotic (1 mg ml À1 ); that is, ampicillin, ciprofloxacin and ceftriaxone, respectively. The plates were then incubated at 37 1C for 24 h. Complete resistance was exhibited by L. plantarum to all three of the tested antibiotics as no inhibition of growth was observed around the wells in any plate. Thus, both of these tests indicated the feasibility of using L. plantarum in conjunction with ampicillin, ciprofloxacin and ceftriaxone.
Cell-free supernatant (CFS) from L. plantarum was prepared by the method as described by Ogunbanwo et al. 9 Briefly, the strain was propagated in 1 l MRS broth (pH 6.5) for 24 h at 37 1C. CFS was obtained by centrifuging the culture at 10 000 r.p.m. for 20 min at 4 1C and was filtered through 0.22 mm pore size cellulose acetate filter.
The MIC of the cell-free extract was estimated to be 640 AU ml À1 , thereby confirming our earlier report. 6 The sensitivity of Salmonella to each of the three antibiotics was also checked and MICs were determined by broth-dilution technique. In brief, 10 7 cells of S. typhimurium were grown individually in the presence of different concentrations (0.03-64 mg ml À1 ) of ampicillin, ciprofloxacin and ceftriaxone in three different 96-well microtitre plates at 37 1C for 24 h. OD was measured at 620 nm using an enzyme-linked immunosorbent assay reader and the MIC was defined as the lowest concentration of each antibiotic not producing any visible microbial growth. The MICs of ampicillin, ciprofloxacin and ceftriaxone were evaluated to be 1 mg ml À1 , 6mg ml À1 and 12 mg ml À1 , respectively. However, according to NCCLS guidelines, S typhimurium was classified as resistant to ceftriaxone and ciprofloxacin, and susceptible to ampicillin as per the MIC breakpoints 10 (for ciprofloxacin and ceftriaxone susceptible (p1), intermediate (1) (2) (3) (4) and resistant (X4), for ampicillin susceptible (p8), intermediate and resistant (X32)).
To evaluate synergy, the fractional inhibitory concentration (FIC) index was determined by checkerboard microtitre test at 64 different combinations. Briefly eight two-fold serial dilutions of each antibiotic and CFS were mixed in checkerboard fashion in a microtitre plate so that each row (and column) contained a fixed amount of one agent and increasing amount of second agent. Concentrations ranging from 0 to 2 MIC were used. The FIC index, obtained by adding both FIC, was interpreted as indicating a synergistic effect when it was p0.5, as additive or indifferent when it was 40.5 and p2.0, and as antagonistic when it was 42.0. 11 The MIC values and FIC index of ampicillin, ciprofloxacin and ceftriaxone and CFS are summarized in Table 1 . The synergistic anti-Salmonella activity of all these combinations was evidenced by the FIC index, which was calculated to be o0.5 in all the three combinations tested ( Table 1) .
The in-vitro synergy as estimated by checkerboard technique was further confirmed by time-kill assay using lower concentrations of each agent in combination. Briefly, ampicillin (1 mg ml À1 ), ciprofloxacin (6 mg ml À1 ), ceftriaxone (12 mg ml À1 ) and CFS (640 AU ml À1 ) alone and their combination, that is, CFS (80 AU ml À1 ) + ampicillin (0.063 mg ml À1 ), CFS (80 AU ml À1 ) + ciprofloxacin (0.75 mg ml À1 ) and CFS (160 AU ml À1 ) + ceftriaxone (1.5 mg ml À1 ), were added to different 20 ml nutrient broth flasks containing 10 6 CFUs of S. typhimurium and incubated at 37 1C. 100 ml aliquots were withdrawn at 0 h, 2 h, 4 h, 6 h and 8 h, and spread plated on MacConkey agar plates. The plates were incubated at 37 1C for 24 h for enumeration of CFUs. When used alone, ampicillin (1 mg ml À1 ) and ciprofloxacin (6 mg ml À1 ) could decrease the CFUs by 5.77 and 5.32 log units, respectively after 8 h as compared with control. However, when used in combination with CFS (80 AU ml À1 ) at much lower concentrations, that is, ampicillin (0.063 mg ml À1 ) and ciprofloxacin (0.75 mg ml À1 ), a decrease of 6.44 log units and 6.27 log units was observed, respectively. Similarly ceftriaxone (12 mg ml À1 ) alone gave a decrease of 5.40 log units, but when used in combination with CFS (160 AU ml À1 ) at a much lower concentration (1.5 mg ml À1 ), a decrease of 5.64 log unit was observed. The results exhibited synergy among all the combinations tested as the dose required to give the same antibacterial effect in terms of CFUs was significantly reduced as compared with when the agents were used separately at higher doses (Figure 1) .
The magnitude of in-vitro synergism observed between CFS and ampicillin prompted us to further investigate the ex-vivo synergistic efficacy in terms of macrophage functions keeping in view the intracellular survival ability of Salmonella. Murine peritoneal macrophages were isolated by the method as described by us earlier 6 and infected with S. typhimurium at a multiplicity of infection of 1:100. Intracellular killing of S. typhimurium was assessed when treated with MIC of both; that is, CFS (640 AU ml À1 ) and ampicillin (1 mg ml À1 ) separately and in combination as per FICs; that is (CFS (80 AU ml À1 ) + ampicillin (0.063mg ml À1 ). After every 30, 60 and 90 min of treatment period, treated and untreated macrophages were pelleted (2000 r.p.m., 10 min) and lysed with 500 ml of 0.25% TritonX-100. Lysates were serially diluted and plated on MacConkey agar medium. After an incubation of 24 h at 37 1C, CFUs were counted. 6 The data were analyzed using one-way analysis of variance followed by pair wise comparison procedures (Tukey test) using Jandel Sigma Stat Statistical Software, version 2.0 (Jandel SigmaStat, Jandel, San Rafael, CA, USA). The mean percentage of intracellular killing in the presence of CFS alone at 30, 60 and 90 min was 17.39% ± 6.52, 29.34% ± 3.81 and 50%±9.24, respectively. Similarly, when infected macrophages were treated with ampicillin alone, the mean intracellular killing was 21.73% ± 4.34, 33.69% ± 6.18 and 53.26% ± 9.78 at 30, 60 and 90 min, respectively. A higher intracellular killing was observed when infected macrophages were treated with ampicillin in conjunction with CFS. In this case, the killing was found to be 30.43% ± 4.98 (Po0.05), 54.34% ± 7.07 (Po0.01) and 83.70% ± 4.34 (Po0.001) at 30, 60 and 90 min, respectively. On the other hand, the intracellular killing in untreated macrophages was 15.22% ± 2.81, 26.08% ± 5.26 and 45.65% ± 3.33 at 30, 60 and 90 min, respectively ( Table 2 ). The results indicate that both CFS and ampicillin might act in conjunction leading to an enhanced killing of intracellular S. typhimurium.
Earlier, chloramphenicol, ampicillin and cotrimoxazole were used to treat Salmonella infections. Later on with the emergence of MDR Figure 1 Time-kill assay. Log 10 CFU of Salmonella typhimurium NCTC74 at various time intervals in presence of ampicillin (1 mg ml À1 ), ciprofloxacin (6 mg ml À1 ), ceftriaxone (12 mg ml À1 ) and CFS (640 AU ml À1 ) alone and their combination; that is, CFS (80 AU ml À1 ) + ampicillin (0.063 mg ml À1 ), CFS (80 AU ml À1 ) + ciprofloxacin (0.75 mg ml À1 ) and CFS (160AUml À1 ) + ceftriaxone (1.5 mg ml À1 ).Values are expressed as mean±s.d. of three individual values. (Synergy is evident among all the combinations tested as the dose required to give the same antibacterial effect in terms of CFUs is significantly reduced as compared with when the agents are being used separately at higher doses).
Salmonella strains, ciprofloxacin became the drug of choice. However, reports of increasing MIC values suggest that ciprofloxacin therapy will not remain effective for much longer. [12] [13] [14] The results of current study exhibited that CFS from L. plantarum has the potential to augment the activity of conventional anti-Salmonella antibiotics as all these three combinations could reduce Salmonella growth significantly. This synergism provides an additional therapeutic choice by allowing the use of conventional antibiotics in conjunction with natural antibiotics against MDR Salmonella. Ampicillin and ceftriaxone, both are b-lactam antibiotics and known to interfere with and inhibit bacterial cell wall synthesis. 15 CFS contains several antimicrobials, 16 lactic and non-lactic acids as well as hydrogen peroxide. It has also been reported that these acids possess bactericidal activity. They can permeate cell membrane by diffusion causing dissipation of membrane proton potential. 17 Synergy between ampicillin/ceftriaxone and CFS could be attributed to the fact that the organic acids present in CFS might have helped increase permeabilization of these antibiotics to the bacterial cell membrane, thereby leading to increased antimicrobial activity.
Ciprofloxacin is a fluoroquinolone, which interferes with the DNA gyrase and inhibits DNA synthesis. CFS from L. plantarum has been reported to contain plantaricin (an antimicrobial peptide of 3.5 kDa) as well. Plantaricin is a pore-forming bacteriocin that acts on permeability barrier of cytoplasmic membrane. 18 The observed synergy might be attributed to the fact that bacteriocin makes pores in the cell membranes, which allows increased amounts of ciprofloxacin to enter the cell and block DNA synthesis. Moreover, quinolones have also been reported to sensitize Gram-negative bacteria to cationic antimicrobial peptides by displacement of divalent cations from their LPS-binding sites thereby increases the binding of antimicrobial peptides to outer membrane. 19 These two mechanisms might have acted mutually leading to enhanced anti-Salmonella effect of this combination.
The most potent combination was found to be that of CFS and ampicillin in terms of FIC index and time-kill assay. It can be hypothesized that CFS may contain compounds capable of inhibiting ampicillin inactivating enzymes such as b-lactamase, thereby making this very combination to be the most effective amongst all the combinations tested. Moreover, the combination also exhibited significant level of killing of Salmonella as per the ex-vivo macrophage study. This observation is in concordance with the earlier reports wherein it was proposed that ampicillin kills intracellular Salmonella within the mouse macrophages owing to its internalization by cells through pinocytosis. 20 Studies have also shown that CFSs and/or extracts from lactic acid producing bacteria may activate macrophages in-vitro thereby resulting in augmented phagocytic activity. 21, 22 These findings can prove to be vital in rejuvenation of ampicillin therapy against Salmonella, as it is no longer used because of worldwide emergence of ampicillin-resistant Salmonella strains.
In conclusion, these combinations demonstrated excellent synergistic in-vitro potency against S. typhimurium. This study points towards the fact that CFS has the potential to augment the activity of the antibiotics at much lower MICs thereby rendering S typhimurium sensitive to ciprofloxacin and ceftriaxone, which was earlier observed to be resistant as per the NCCLS guidelines. 10 Although the observations of the present study indicate that CFS has the potential to augment the efficacy of antibiotics but the possibility of transfer of resistance genes from L. plantarum (if given as such) to Salmonella cannot be ruled out as has been reported in case of other microorganisms. 23, 24 This issue needs to be explored further in reference to Salmonella infections. 
